A four-part investigation into the next generation of therapy delivery: who is building it, how distribution actually works, what the unit economics say, and whether anything in this category produces measurable outcomes at scale.
In the eighteen months since the Talkspace re-orientation, every founder and investor I speak with is asking the same question, in slightly different language: is the therapy layer a software business, a clinical business, or a benefits business? The answer rotates the equity story.
I have been carrying this question through every interview, earnings call and chapter dinner since January. Across four parts, I'll show you what I have found — the operators who have actually answered it, the operators who haven't, and what the next twenty-four months of consolidation are likely to look like as a result.
A taxonomy of the eleven operators who matter. What separates a real platform (Kooth, LifeStance, Mindset) from a wrapper. Why the consumer-first builders cannot get there from here.
Why Mindset and Kooth are running models that BetterHelp and Cerebral cannot copy on their existing balance sheet. The procurement-cycle moat, with two contract examples.
A model walk-through. Per-population vs. per-user vs. per-MPM. How the gross margin actually compounds when you size clinical headcount to peak concurrency. Three scenarios on US state penetration.
The hardest part. What we know about effect sizes from the published Kooth, Lyra and Spring Health data. What we don't know. The honest answer to whether digital-first therapy produces measurable population outcomes.
Parts III and IV ship to Pro members. So does the full Kooth model, the Pennsylvania contract breakdown, and a 410-operator Slack that you cannot get into any other way.
